Works by Kaminski, Mark S.

Results: 42
    1
    2

    Fetal Dose from PET and CT in Pregnant Patients.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 312, doi. 10.2967/jnumed.122.263959
    By:
    • Burton, Christiane Sarah;
    • Frey, Kirk;
    • Fahey, Frederic;
    • Kaminski, Mark S.;
    • Brown, Richard K. J.;
    • Pohlen, Judith M.;
    • Shulkin, Barry L.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 7, p. 1271, doi. 10.3109/10428194.2011.567316
    By:
    • Dytfeld, Dominik;
    • Griffith, Kent A.;
    • Friedman, Judah;
    • Lebovic, Daniel;
    • Harvey, Colleen;
    • Kaminski, Mark S.;
    • Jakubowiak, Andrzej J.
    Publication type:
    Article
    15
    16

    Clinical application of next generation sequencing in lymphoma.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 4, p. 868, doi. 10.1080/10428194.2020.1846734
    By:
    • Scott, Anthony J.;
    • Tokaz, Molly C.;
    • Shango, Maryann;
    • Devata, Sumana;
    • Carty, Shannon A.;
    • Kaminski, Mark S.;
    • Chinnaiyan, Arul M.;
    • Phillips, Tycel J.;
    • Wilcox, Ryan A.
    Publication type:
    Article
    17
    18

    Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 894, doi. 10.1080/10428194.2018.1515940
    By:
    • Sharman, Jeff P.;
    • Forero-Torres, Andres;
    • Costa, Luciano J.;
    • Flinn, Ian W.;
    • Inhorn, Lowell;
    • Kelly, Kevin;
    • Bessudo, Alberto;
    • Fayad, Luis E.;
    • Kaminski, Mark S.;
    • Evens, Andrew M.;
    • Flowers, Christopher R.;
    • Sahin, Deniz;
    • Mundt, Kirsten E.;
    • Sandmann, Thomas;
    • Fingerle-Rowson, Günter;
    • Vignal, Charlotte;
    • Mobasher, Mehrdad;
    • Zelenetz, Andrew D.
    Publication type:
    Article
    19

    Survival in patients with limited-stage peripheral T-cell lymphomas.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1665, doi. 10.3109/10428194.2014.963078
    By:
    • Briski, Robert;
    • Feldman, Andrew L.;
    • Bailey, Nathaniel G.;
    • Lim, Megan S.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Macon, William R.;
    • Inwards, David J.;
    • Colgan, Joseph P.;
    • Nowakowski, Grzegorz S.;
    • Kaminski, Mark S.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Wilcox, Ryan A.
    Publication type:
    Article
    20

    Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with <sup>131</sup>I-tositumomab.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 2, p. 342, doi. 10.3109/10428194.2014.914195
    By:
    • Elstrom, Rebecca L.;
    • Ruan, Jia;
    • Christos, Paul J.;
    • Martin, Peter;
    • Lebovic, Daniel;
    • Osborne, Joseph;
    • Goldsmith, Stanley;
    • Greenberg, June;
    • Furman, Richard R.;
    • Avram, Anca;
    • Putman, Ryan;
    • Chapman, Erica;
    • Mazumdar, Madhu;
    • Griffith, Kent;
    • Coleman, Morton;
    • Leonard, John P.;
    • Kaminski, Mark S.
    Publication type:
    Article
    21
    22

    Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.

    Published in:
    British Journal of Haematology, 2014, v. 165, n. 4, p. 510, doi. 10.1111/bjh.12780
    By:
    • Wang, Michael;
    • Popplewell, Leslie L.;
    • Collins, Robert H.;
    • Winter, Jane N.;
    • Goy, Andre;
    • Kaminski, Mark S.;
    • Bartlett, Nancy L.;
    • Johnston, Patrick B.;
    • Lister, John;
    • Fanning, Suzanne R.;
    • Tuscano, Joseph M.;
    • Beck, J. Thaddeus;
    • Kaya, Hakan;
    • Robeva, Anna;
    • Fan, Jenna;
    • Klimovsky, Judith;
    • Cheung, Wing;
    • Cherfi, Azzeddine;
    • O'Connor, Owen A.
    Publication type:
    Article
    23

    Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 4, p. 487, doi. 10.1111/bjh.12570
    By:
    • Ban‐Hoefen, Makiko;
    • Vanderplas, Ann;
    • Crosby‐Thompson, Allison L.;
    • Abel, Gregory A.;
    • Czuczman, Myron S.;
    • Gordon, Leo I.;
    • Kaminski, Mark S.;
    • Kelly, Jennifer;
    • Millenson, Michael;
    • Nademanee, Auayporn P.;
    • Rodriguez, Maria A.;
    • Zelenetz, Andrew D.;
    • Niland, Joyce;
    • LaCasce, Ann S.;
    • Friedberg, Jonathan W.
    Publication type:
    Article
    24
    25
    26
    27
    28

    Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 13, p. 1993, doi. 10.1002/cncr.28676
    By:
    • Herrera, Alex F.;
    • Crosby‐Thompson, Allison;
    • Friedberg, Jonathan W.;
    • Abel, Gregory A.;
    • Czuczman, Myron S.;
    • Gordon, Leo I.;
    • Kaminski, Mark S.;
    • Millenson, Michael M.;
    • Nademanee, Auayporn P.;
    • Niland, Joyce C.;
    • Rodig, Scott J.;
    • Rodriguez, Maria A.;
    • Zelenetz, Andrew D.;
    • LaCasce, Ann S.
    Publication type:
    Article
    29
    30
    31
    32

    Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 2, p. 255, doi. 10.1111/bjh.15923
    By:
    • Geer, Marcus;
    • Roberts, Emily;
    • Shango, Maryann;
    • Till, Brian G.;
    • Smith, Stephen D.;
    • Abbas, Hashim;
    • Hill, Brian T.;
    • Kaplan, Jason;
    • Barr, Paul M.;
    • Caimi, Paolo;
    • Stephens, Deborah M.;
    • Lin, Emily;
    • Herrera, Alex F.;
    • Rosenbaum, Evan;
    • Amengual, Jennifer E.;
    • Boonstra, Philip S.;
    • Devata, Sumana;
    • Wilcox, Ryan A.;
    • Kaminski, Mark S.;
    • Phillips, Tycel J.
    Publication type:
    Article
    33
    34

    Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.

    Published in:
    2017
    By:
    • Moinpour, Carol;
    • Unger, Joseph;
    • Ganz, Patricia;
    • Kornblith, Alice;
    • Gaynor, Ellen;
    • Bowers, Mindy;
    • Gatti, Gretchen;
    • Kaminski, Mark S.;
    • Erba, Harry;
    • Wang, Ting;
    • Yoon, Jihye;
    • Press, Oliver;
    • Fisher, Richard;
    • Moinpour, Carol M;
    • Unger, Joseph M;
    • Ganz, Patricia A;
    • Kornblith, Alice B;
    • Gaynor, Ellen R;
    • Bowers, Mindy Ann;
    • Gatti, Gretchen S
    Publication type:
    journal article
    35
    36
    37
    38
    39
    40
    41
    42